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 Heterogeneity of iron phases imaged at sub-micron length scales 
 Sensitivity to neuromelanin-bound iron in 500 nm thick sections 
 
 
Abstract 
Background 
Neuromelanin-pigmented neurons, which are highly susceptible to neurodegeneration in the 
Parkinson’s disease substantia nigra, harbour elevated iron levels in the diseased state. Whilst 
it is widely believed that neuronal iron is stored in an inert, ferric form, perturbations to normal 
metal homeostasis could potentially generate more reactive forms of iron capable of 
stimulating toxicity and cell death. However, non-disruptive analysis of brain metals is 
inherently challenging, since use of stains or chemical fixatives, for example, can significantly 
influence metal ion distributions and/or concentrations in tissues. 
Aims 
The aim of this study was to apply synchrotron soft x-ray spectromicroscopy to the 
characterisation of iron deposits and their local environment within neuromelanin-containing  
neurons of Parkinson’s disease substantia nigra.  
Methods 
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Soft x-ray spectromicroscopy was applied in the form of Scanning Transmission X-ray 
Microscopy (STXM) to analyse resin-embedded tissue, without requirement for chemically 
disruptive processing or staining. Measurements were performed at the oxygen and iron K-
edges in order to characterise both organic and inorganic components of anatomical tissue 
using a single label-free method. 
Results 
STXM revealed evidence for mixed oxidation states of neuronal iron deposits associated with 
neuromelanin clusters in Parkinson’s disease substantia nigra. The excellent sensitivity, 
specificity and spatial resolution of these STXM measurements showed that the iron oxidation 
state varies across sub-micron length scales. 
Conclusions 
The label-free STXM approach is highly suited to characterising the distributions of both 
inorganic and organic components of anatomical tissue, and provides a proof-of-concept for 
investigating trace metal speciation within Parkinson’s disease neuromelanin-containing 
neurons.   
Key Words: 
Parkinson’s disease; Iron; Oxidation state; Soft x-ray; Spectromicroscopy; Synchrotron 
Introduction 
Many neurodegenerative disorders are associated with altered metal ion metabolism in the 
brain [1]. In Parkinson’s disease (PD), iron levels are significantly elevated in the type of nerve 
cell most severely compromised by disease progression – the dopaminergic neurons within 
the substantia nigra pars compacta (SNc) region [2]. Death of these vulnerable dopamine-
producing neurons ultimately leads to a severe depletion of striatal dopamine, inducing the 
characteristic symptoms of PD such as tremor, rigidity and bradykinesia. Although trace 
metals are essential for normal physiological brain function, localised perturbations to metal 
homeostasis could potentially be responsible for initiating toxicity and region-specific cell 
death [3-5]. Thus, it is critical to develop methods capable of characterising changes in metal 
chemistry at a subcellular level.  
The high rate of oxidative metabolism and augmented iron concentrations leave the brain 
particularly susceptible to oxidative stress [6]. Whilst redox switching between ferric (Fe3+) and 
ferrous (Fe2+) forms is key to iron’s functional role in neurotransmitter synthesis, myelin 
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synthesis and cellular metabolism [3], these reactions can also generate reactive oxygen 
species which are highly toxic to cells via Fenton and related redox chemistry [3, 7]. Strict 
regulatory systems must be appropriately maintained to ensure a sufficient supply of iron for 
essential processes whilst protecting vulnerable neurons from iron-mediated toxicity.  
Whilst iron storage protein, ferritin, is the dominant iron sink in glial cells of the SNc, iron in 
nigral neurons is primarily bound by the biological polymer, neuromelanin (NM) [8, 9]. NM 
pigments dopaminergic neurons of the SNc and noradrenergic neurons in the locus coeruleus, 
the two brain regions most susceptible to neuron loss during the progression of PD [10]. 
Similar to ferritin, NM also sequesters ferrous iron and binds it in a redox-stabilised ferric form, 
forming iron oxide clusters which comprise around 10 – 20% of total iron in the substantia 
nigra [11]. It has been proposed that the antioxidant defences offered by iron-binding 
molecules such as ferritin and NM may be impaired by the ageing process, thereby increasing 
vulnerability towards age-related neurodegeneration. [3, 12]. Moreover, it is possible that the 
storage capacity of these iron reservoirs may be particularly compromised in PD, leading to 
hazardous levels of redox-active iron contained within, or in the immediate vicinity of 
vulnerable neurons [13-15]. 
Despite the potential implications for disease-specific iron dysregulation in PD, there has only 
been limited exploration of interactions between iron and NM in PD substantia nigra using 
high-resolution spectromicroscopy [16]. This is chiefly because non-disruptive, label-free 
analysis of brain metals poses significant inherent analytical challenges, whereas use of stains 
or chemical fixatives can significantly influence metal ion distributions and/or concentrations in 
tissues [17-19]. Synchrotron-based techniques to study subcellular structure and chemistry in 
disease pathology are consequently of current interest [20], since these methods can be applied 
without sample ablation or requirement for additional staining (i.e. they are label-free) [21]. 
Recent developments in soft x-ray synchrotron techniques represent a pivotal advancement in 
this field, allowing inorganic metal distributions to be visualised with respect to organic, 
anatomical tissue structure.  
Scanning Transmission X-ray Microscopy (STXM) is one such synchrotron-based, soft x-ray 
approach, particularly suited to providing combined imaging and spectral data on biological 
tissue samples. In STXM, the energy of the incident beam can be precisely tuned and stepped 
over a desired range to generate x-ray absorption spectra over a targeted absorption edge (e.g. 
carbon or iron K-edges). The high energy resolution attainable with STXM (ca. 0.1 eV) promotes 
sensitivity towards chemical variations in the sample, allowing speciation of endogenous metal 
ions. Image contrast can also be generated by exploiting distinct spectral features to create 
speciation maps, illustrating not only the distribution of individual elements, but the distribution 
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of specific molecules and ions (e.g. proteins, Fe2+/Fe3+). This powerful analytical tool has 
previously been applied to perform specific mapping of organic tissue components [21] and to 
advance understanding of Alzheimer’s disease aetiology, characterising  interactions between 
metal ions and the amyloid-beta peptide in both in vitro [22-24] and ex vivo [25] studies. 
The aim of this study was to apply STXM to the characterisation of iron deposits and their local 
environment within neuromelanin-containing neurons of Parkinson’s disease SNc. Combined 
imaging and spectral data was used to demonstrate the heterogeneous structure and 
composition of post-mortem brain tissue samples, whilst also detecting variations in the 
oxidation state of neuronal iron.  
Materials and methods 
Tissue Preparation 
Frozen, unfixed substantia nigra tissue from a confirmed PD case was obtained from the 
Canadian Brain Tissue Bank and prepared and analysed under current ethical approvals 
07/MRE08/12 and REGO-2018-2223. 
Substantia nigra tissue was cut into cubes approximately 8 mm3 in size using a non-metallic 
knife to prevent metal contamination, and dehydrated using an ethanol series (40%-100% 
dry). Following dehydration, tissue cubes were embedded in an aliphatic epoxy resin 
composed of an equimolar mixture of trimethylolpropane triglycidyl ether and 4,4’-
methylenebis-(2-methylcyclohexylamine), purchased from Sigma Aldrich (Dorset, UK), and 
cured at 60°C overnight.  
Prior work demonstrated that ferric iron standards prepared using the same embedding series 
as for the substantia nigra tissue show no evidence of iron reduction when examined using 
STXM [26]. Thus, whilst the absolute concentrations of loosely-bound metal ions may be 
altered by the resin-embedding process, it is likely that iron oxidation state is preserved.  
For soft x-ray spectromicroscopy (STXM) experiments, semi-thin, 500 nm thick sections of 
resin embedded substantia nigra tissue were cut using a Reichert-Jung ultra-cut microtome, 
operating with a diamond blade (DiATOME Ultra 45°). Sections were mounted on copper 
TEM grids for STXM examination. No dyes or contrast agents were applied. 
 Scanning Transmission X-ray Microscopy 
STXM experiments were performed on Diamond Light Source beamline I08 (Oxfordshire, UK), 
and the Advanced Light Source beamline 11.0.2 (Berkeley, CA, USA). Microscopy images 
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were obtained by tuning the incident x-ray beam to a specific energy, raster scanning the 
sample across a focussed beam of <50 nm spot size, and recording the transmitted X-ray 
intensity. Exposure times were kept to a minimum (≤10 ms per point) to prevent radiation 
damage.  
Speciation maps showing the nanoscale distribution of particular elements or chemical states 
were generated by collecting paired images: a “peak” image at the energy corresponding to a 
feature of interest (e.g. the principal Fe3+ L3-edge peak at 709.5 eV), and an “off-peak” image 
a few eV below this feature. The off-peak image was then subtracted from the peak image 
providing a speciation map devoid of artefacts (from for example, the embedding resin). 
Speciation maps were created for features at the oxygen K-edge (520-545 eV) and the iron 
L3-edge (700-716 eV).  
Iron L3-edge x-ray absorption spectra providing detailed information regarding the oxidation 
state of the measured iron deposits, were obtained by collecting images of a region of interest 
at multiple x-ray energies across the absorption edge. Normalisation of the x-ray absorption 
spectra was achieved by converting the raw x-ray absorption intensities to optical density 
using background regions that did not contain any iron material (e.g. areas of the resin that 
are devoid of tissue). The “dark count”, i.e. the background noise attributable to the beamline, 
was determined by acquiring a single image with no incident x-ray beam and subtracted from 
the stack before conversion to optical density. By performing this form of spectromicroscopy, 
x-ray absorption spectra can be generated from each pixel of an image, allowing the iron 
oxidation state from highly localized (<50 nm) regions of interest to be determined. A three-
point average smoothing was applied to all iron L3-edge x-ray absorption spectra collected. 
STXM data processing was performed using the aXis 2000 software package 
(http://unicorn.mcmaster.ca/aXis2000.html). Pseudo-coloured composite images were 
created by converting greyscale images to false colour, before recombining the images as an 
overlay using ImageJ. 
Results 
STXM images, speciation maps and an iron L3-edge x-ray absorption spectrum from a 
neuromelanin-containing neuron within an embedded section of PD substantia nigra are 
shown in Figure 1. An oxygen K-edge speciation map taken at 532 eV, displaying tissue 
ultrastructure, is shown in Figure 1a. From this map a clear cell border and intracellular 
structure can be seen. An off-resonance 530 eV image is shown in Figure 1b, in which an 
intracellular cluster of NM is visible as a region of high contrast, owing to NM’s higher optical 
density compared to the surrounding neuropil at this energy. Iron L3-edge mapping of the 
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neuron at 709.5 eV (Figure 1d), showed a cellular iron distribution which closely matches that 
of NM (Figure 1b, e), suggesting that NM is loaded with iron. 
To establish the oxidation state of the NM-associated iron, x-ray spectromicroscopy was 
performed over the iron L3-edge. At the L3-edge, ferric (Fe3+) materials display a principal 
absorption peak at 709.5 eV and a further low intensity peak at 708 eV (for reference spectrum 
see Figure 1f; orange spectrum).  In contrast, pure ferrous (Fe2+) materials display a single 
peak at 708 eV (see Figure 1f; green spectrum). Therefore, increases in the Fe2+ content of 
an originally ferric material result in an increased peak intensity at 708 eV with respect to the 
feature at 709.5 eV. The iron L3-edge x-ray absorption spectrum from the NM-associated iron 
(Figure 1f; blue spectrum) strongly resembled the ferrous standard, demonstrating this iron to 
be predominantly Fe2+.  
Figure 1. X-ray speciation maps, images and an iron L3-edge x-ray absorption spectrum from a neuromelanin-
containing neuron within a PD substantia nigra tissue section. (a) Oxygen K-edge tissue map. (b) Off-peak 530 eV 
image, showing NM granules as areas of strong contrast. (c) Composite image displaying tissue (cyan) and NM 
(red) content. (d) Iron L3-edge speciation map and (e) composite image displaying iron (blue) and NM (red), from 
the area highlighted in (b). (f) Iron L3-edge spectrum (blue) from the NM area shown in (d). Ferric (Fe3+; orange) 
and ferrous (Fe2+; green) standard spectra are also provided for reference.    
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A STXM image and iron L3-edge x-ray absorption spectra from a further NM cluster located 
within the same tissue section are shown in Figure 2. In the 709.5 eV image (Figure 2a), a 
large >15 µm diameter cluster of NM is evident, within which, individual NM granules (<600 
nm diameter) can be resolved.  
Iron L3-edge x-ray absorption spectra from five, individual NM granules are shown in Figure 
2b. Even within nanoscale regions, a clear variation in iron oxidation state can be seen in the 
different NM granules. The spectra from the areas labelled B1-B2 are characteristic of a Fe3+ 
phase. In contrast, spectra B3→B5 displayed increased Fe2+ features, as evidenced by the 
enhancement of the feature at 708 eV in relation to the principal Fe3+ peak at 709.5 eV, and 
are plotted in ascending order with regards to their Fe2+ content. These results again show the 
presence of chemically reduced iron associated with NM in PD substantia nigra, and suggest 
that the degree of reduction can vary between adjacent NM granules. 
Figure 2. (a) An iron L3-edge x-ray image and (b) x-ray absorption spectra from NM granules in a PD substantia 
nigra tissue section, demonstrating nanoscale variation in iron oxidation state. X-ray spectra in (b) correspond to 
the areas highlighted in (a). The dotted-dashed line at 708 eV in (b) indicates the peak absorption energy for Fe2+.   
5 µm
(a) 709.5 eV
B1
(b)
704 706 708 710 712 714 716
B5
B4
B3
B2
X
-r
a
y
 a
b
s
o
rp
ti
o
n
 (
a
rb
. 
u
n
it
s
)
Energy (eV)
B1
Jo
urn
al 
Pre
-pr
oo
f
8 
 
Discussion 
Despite the association between elevated iron levels and PD having been recognised for 
nearly a century, the mechanisms linking iron dysregulation and  neurotoxicity are not yet fully 
understood, and it remains unclear as to why dopaminergic neurons in the SNc are so heavily 
affected by neurodegeneration, whilst other iron-rich nuclei are spared [13]. 
This work demonstrates that STXM is a powerful tool for analysing NM clusters and associated 
iron distributions within neuromelanin-containing neurons, without requirement for chemically 
disruptive staining. The ability to characterise metal ion distributions in context with the 
surrounding anatomical tissue structure without labelling offers unique potential to investigate 
the native chemistry of tissue samples in situ. This is particularly pertinent to analysis of 
vulnerable neuromelanin-containing neurons in the PD substantia nigra, where elevated iron 
levels have consistently been reported [2, 27, 28]. 
The positive identification of NM was informed by related recently-published work confirming 
the utility of STXM for label-free imaging of NM [21]. Spectral features shared by NM clusters 
and synthetic NM were used to create speciation maps demonstrating equivalent distributional 
information to that obtained from silver nitrate staining in consecutive tissue sections [21]. 
Because STXM signal relies on energy-dependent x-ray transmission through the resin-
embedded tissue sections, and on analyte concentration at a specific absorption edge, the 
prior NM labelling work was optimised at the lower-energy carbon K-edge in thinner (200 nm) 
sections. In the present study, thicker 500 nm sections were used to maximise iron signal for 
the chemical speciation of NM-associated iron. In these 500 nm sections we confirmed that 
the off-resonance signal near the oxygen edge (530 eV, Figure 1), evidences sufficient 
contrast from the NM clusters that the NM distribution and chemical speciation of NM-
associated iron could be studied in a single section, as illustrated here. NM granules were 
distinguished by their characteristic granular morphology and increased optical density relative 
to surrounding cellular ultrastructure at the oxygen K-edge. We note that both the morphology 
and surrounding cellular context of large intracellular neuromelanin clusters were entirely 
consistent with large intracellular neuromelanin clusters observed previously using silver 
nitrate labelling, or optimised carbon K-edge STXM mapping [21]. 
We show that x-ray spectromicroscopy using STXM provides sufficiently high spatial 
resolution and chemical sensitivity to allow acquisition of x-ray absorption spectra from 
individual NM granules. Dense clusters of NM approximately 300-500 nm in diameter are 
shown to be loaded with iron, consistent with the well-documented high affinity of NM for metal 
ions [29-31]. Nanoscale variations in iron oxidation state were observed amongst NM 
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granules, highlighting the need for nanoscale spatial resolution when examining the 
biochemistry of tissue samples, whilst also drawing attention to the remarkable specificity of 
STXM for speciation analysis.  
Destructive microprobe techniques such as laser ablation inductively coupled plasma mass 
spectrometry (LA-ICP-MS) have been utilised effectively for the purpose of quantifying metal 
concentrations in targeted regions of tissue [32, 33]. Whilst such techniques are ideally suited 
to quantification and can certainly achieve exceptional chemical sensitivity, the capacity to 
distinguish different metal species or to measure regions on the nanoscale is lacking [34]. 
STXM can elucidate metal speciation on the nanoscale, whilst also preserving the sample for 
complementary analysis. The ability to acquire large volumes of data from small volumes of 
sample is particularly important to post-mortem tissue studies, where sample supply is 
necessarily constrained [35]. 
With iron typically stored in a ferric (Fe3+) state within NM granules, the presence of chemically 
reduced iron is certainly intriguing with regards to the hypothesis that the antioxidant metal-
binding function of NM may be compromised by ageing, or even specifically in Parkinson’s 
disease [13-15]. NM-bound iron clusters measured with identical x-ray doses showed both 
ferric and ferrous-rich forms of iron. We have previously shown that such effects are not 
caused by artefacts  such as x-ray beam reduction [25]; therefore, the localised variation in 
iron oxidation state supports the possibility of redox cycling between ferric (Fe3+) and ferrous 
(Fe2+) ions, potentially accompanied by generation of toxic species such as free radicals. 
Redox cycling of metal ions (including iron, manganese and copper) may be instrumental in 
exacerbating oxidative stress in the brain, a mechanism which is receiving growing attention 
concerning its association with neurodegeneration and ageing in general [4, 36-38]. The 
results shown here provide proof-of-concept using tissue from a single PD case. The highly 
localised variations in iron oxidation state within neuromelanin-containing neurons clearly 
warrants further investigation, to incorporate additional PD cases, and neurologically healthy 
controls. 
In summary, we demonstrate that soft x-ray spectromicroscopy using STXM offers a level of 
information which would normally demand extensive application of multiple complementary 
techniques, each requiring independent sample preparation. The detection of signals for both 
organic and inorganic components, combined with the high spatial resolution, specificity, and 
sensitivity for trace metal detection, makes STXM a powerful method for in-depth studies on 
disrupted biochemistry in the PD brain.  
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